InfuSystem
INFU
$8.90
Share price
0.00%
Change (1 day)
-7.39%
Change (1 year)
Categories
Revenue for InfuSystem (INFU)
Revenue in 2023 (TTM): $0.11 B
According to InfuSystem's latest financial reports the company's current revenue (TTM) is $0.11 B. In 2022 the company made a revenue of $0.10 B an increase over the years 2021 revenue that were of $0.10 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for InfuSystem from 2008 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.11 B | 3.28% |
| 2022 | $0.10 B | 7.36% |
| 2021 | $0.10 B | 5.13% |
| 2020 | $97.38 M | 20.06% |
| 2019 | $81.11 M | 20.82% |
| 2018 | $67.13 M | -5.54% |
| 2017 | $71.07 M | -1.54% |
| 2016 | $72.19 M | 0.09% |
| 2015 | $72.12 M | 8.48% |
| 2014 | $66.48 M | 6.75% |
| 2013 | $62.28 M | 5.87% |
| 2012 | $58.82 M | 7.67% |
| 2011 | $54.63 M | 15.69% |
| 2010 | $47.22 M | 21.21% |
| 2009 | $38.96 M | 10.02% |
| 2008 | $35.41 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Premier PINC | $1.33 B | 1,077.26% | 🇺🇸 USA |
 DexCom DXCM | $3.02 B | 2,562.50% | 🇺🇸 USA |
 CorVel Corporation
CRVL | $0.70 B | 520.57% | 🇺🇸 USA |
 Biolase
BIOL | $48.46 M | -57.31% | 🇺🇸 USA |